Clopidogrel (Plavix®) use in cats
of an assay to measure blood concentrations of the clopidogrel active
metabolite in cats clinically receiving clopidogrel."
Purpose of Study
The purpose of this study is to evaluate the properties of
clopidogrel (Plavix® ) in felines. Cats
with heart disease can be prone to forming clots in their hearts.
These clots can leave the heart, travel to any part of the body and
block blood flow. This is a very painful condition and, depending
on the location of the clot, can come with a very poor prognosis.
In humans, clopidogrel is used to decrease blood clot formation but not
much is known about its properties in cats. Obtaining more
information about this drug will help veterinarians provide better
treatment for cats who are prone to life-threatening blood clots.
Enrolled cats will receive a free physical examination from a board
certified veterinary cardiologist. The study will cover the costs
of blood work and associated analysis.
Cats who qualify for this study must be currently receiving or
scheduled to start clopidogrel. They will spend about three hours
at the WSU-VTH for a physical examination and either one or two blood
Once enrolled, the cat will receive a physical exam. After the
physical exam, 6.0 ml of blood (a little over 1 teaspoon) will be
If the cat is enrolled for two blood draws, the cardiologist will wait
for 2 hours before drawing another 6.0 ml of blood.
Owners are responsible for bringing their cat to the WSU-VTH on the
arranged day of the exam and blood draw.
For more information please contact Valorie Wiss, Clinical Studies
(Office: 509-335-0798, Cell: 509-432-5345 or